Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-27T12:16:28.392Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis

Published online by Cambridge University Press:  06 April 2009

J. F. Magnaval
J. F. Magnaval
Affiliation:
Laboratoire de Parasitologie, CHU Purpan 31059, Toulouse Cedex, France
Get access Rights & Permissions [Opens in a new window]

Summary

An open randomized study was carried out to assess the efficacy of diethylcarbamazine (DEC) and mebendazole (MBZ) across, respectively, 39 and 41 patients, all exhibiting clinical and biological features evocative of toxocariasis, together with a positive immunodiagnosis by Western blot using Toxocara larvae excretory-secretory antigens. Clinical impact of the disease was quantified by a score system (20 parameters). Post-treatment follow-up used also results from eosinophil counts from total and specific anti-Toxocara IgE quantitations, and from Western blots. All patients attended the control check-up 1 month after the end of treatment. Analysis of the results showed a similar good efficacy of DEC and MBZ on clinical score and eosinophil count that were significantly lowered. MBZ therapy was slightly more efficient on specific anti-Toxocara IgE kinetics, while total IgE mean titres were not affected by either DEC or MBZ treatment. Patients from the DEC group reported a significantly higher rate of adverse reactions, most of which could be due to parasite lysis. This fact could be a strong argument for treating human toxocariasis with MBZ.

Keywords

toxocariasistreatmentopen randomized studydiethylcarbamazinemebendazole
Type
Research Article
Information
Parasitology , Volume 110 , Issue 5 , June 1995 , pp. 529 - 533
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Bass, J. L., Mehta, K. A., Glickman, L. T., Blocker, R. & Eppes, B. M. (1987). Asymoptomatic toxocariasis in children. Clinical Pediatrics 26, 441–6.CrossRefGoogle Scholar
Beaver, P. C. (1956). Larva migrans. Experimental Parasitology 5, 587–621.CrossRefGoogle ScholarPubMed
Begaud, B., Evreux, C., Jouglard, J. & Lagier, G. (1985). Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France. Thérapie 40, 115–18.Google ScholarPubMed
de Carli, M., Romagnani, S. & Del, Prete G. (1993). Human T-cell response to the antigens of Toxocara canis. A model of preferential in vitro and in vivo activation of Th2 cells. In Toxocara and Toxocariasis (ed Lewis, J. W. & Maizels, R. M.), pp. 125–132. London: British Society for Parasitology.Google Scholar
Savigny, De D. H. (1975). In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigens for use in serodiagnostic tests for visceral larva migrans. Journal of Parasitology 61, 781–2.CrossRefGoogle Scholar
Glickman, L. T. & Magnaval, J.-F. (1993). Zoonotic roundworm infections. Infectious Disease Clinics of North America 7, 717–32.CrossRefGoogle ScholarPubMed
Glickman, L. T., Magnaval, J.-F., Domanski, L. M., Shofer, F. S., Lauria, S. S., Gottstein, B & Brochier, B. (1987). Visceral larva migrans in French adults: a new disease syndrome? American Journal of Epidemiology 125, 1019–34.CrossRefGoogle ScholarPubMed
Magnaval, J.-F. (1993). Toxocariasis in the Midi-Pyrénées region. In Toxocara and Toxocariasis (ed. Lewis, J. W. & Maizels, R. M.), pp. 63–69. London: British Society for Parasitology.Google Scholar
Magnaval, J.-F. & Charlet, J.-P. (1987). Efficacité comparée du thiabendazole et du mébendazole dans le traitement de la toxocarose humaine. Thérapie 42, 541–4.Google Scholar
Magnaval, J.-F., Charlet, J.-P. & De Larrard, B. (1992 a). Etude double aveugle de l'efHcacité du mébendazole dans les formes mineures de la toxocarose humaine. Therapie 47, 145–8.Google Scholar
Magnaval, J.-F., Fabre, R., Maurières, P., Charlet, J.-P. & De Larrard, B. (1991). Application of the Western-blotting procedure for the immunodiagnosis of human toxocariasis. Parasitology Research 77, 697–702.CrossRefGoogle ScholarPubMed
Magnaval, J.-F., Fabre, R., Maurières, P., Charlet, J.-P. & De Larrard, B. (1992 b). Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis. Journal of Clinical Microbiology 30, 2269–74.CrossRefGoogle ScholarPubMed
Molk, R. (1983). Ocular toxocariasis. A review of the literature. Annals of Ophthalmology 15, 216–31.Google ScholarPubMed
Piessens, W. & Beldekas, M. (1979). Diethylcarbamazine enhances antibody-mediated cellular adherence to Brugia malayi microfilariae. Nature, London 282, 845–7.CrossRefGoogle ScholarPubMed
Romagnani, S. (1990). Regulation and deregulation of human IgE synthesis. Immunology Today 11, 316–21.CrossRefGoogle ScholarPubMed
Schantz, P. M. (1989). Toxocara larva migrans now. American Journal of Tropical Medicine and Hygiene 41, 21–34 (Suppl).CrossRefGoogle ScholarPubMed
Soulsby, E. J. L. (1987). Larva migrans in perspective. In Helminth Zoonoses (ed. Geerts, S., Kumar, V. & Brandt, J.), pp. 137–148. Dordrecht: Martinus Nijhoff.CrossRefGoogle Scholar
Stürchler, D., Schubarth, P., Gualzata, M., Gottstein, B. & Oettli, A. (1989). Thiabendazole vs albendazole in treatment of toxocariasis. Annals of Tropical Medicine and Parasitology 83, 473–6.CrossRefGoogle ScholarPubMed
Taylor, M. R., Keane, C. T., O'Connor, P., Muvihill, E. & Holland, C. (1988). The expanded spectrum of toxocaral disease. Lancet i, 692–4.CrossRefGoogle ScholarPubMed
Hoegaerden, Van M., Ivanoff, B., Flocard, F., Salle, A. & Chabaud, B. (1987). The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella Persians. Annals of Tropical Medicine and Parasitology 81, 275–82.CrossRefGoogle Scholar
Witassek, F., Burkhardt, B., Eckert, J. & Bircher, J. (1981). Chemotherapy of alveolar echinococcosis. Comparison of plasma mebendazole concentrations in Animal and Man. European Journal of Pharmacology 20, 427–33.Google ScholarPubMed